Main findings Although dementia was uncommon, the large sample size afforded by the study allowed us to identify a highly significant reduction in risk of dementia in cDMARD users versus nonusers, these being 0.5% versus 1.6% at 5 years and 1.5% versus 3.0% at 15 years.
← all excerpts
Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients.
1
—
—